Zilico's flagship product ZedScan, can identify potential areas of disease in the cervix earlier than traditional colposcopy methods, which have remained relatively unchanged for decades. Messaging needed to be carefully considered so as not to alienate colposcopists by suggesting they were misdiagnosing.
A long term strategic approach was undertaken, including key messages and positioning, giving the organisation and distributors cohesive and consistent communications. Channels included social media campaigns, digital marketing solutions and hosted materials including hybrid digital and paper-based; product brochures, flyers, conference materials and brand book.